| accession | P01130 |
| Source | DNA sequence encoding Human LDLR including a C-His-Avi tag was expressed in HEK293 Cells. The recombinant protein was then biotinylated site specific using the AVItag biotinylation technology. |
| Molecular weight | Recombinant Human LDLR is a protein consisting of amino acid residues [Ala22-Arg788] ,The protein has a predicted MW of 87.6 kDa, Due to glycosylation, the protein migrates to 110-130 kDa based on Tris-Bis PAGE result.. |
| Purity | >95%, as determined by SDS-PAGE and HPLC |
| Biological Activity | see methods section |
| Endotoxin | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg(1EU/µg). |
| Presentation | Recombinant Human LDLR was lyophilized from 0.2 µm filtered PBS solution pH7.4 |
| Reconstitution | Centrifuge vial to ensure maximal product extraction, recommended:20sec, 5K RPM |
| Storage | The lyophilized protein is stable for at least 2 years from date of receipt at -20° C. |
| Usage | This product is for research purposes only.It may not be used for therapeutics or diagnostic purposes. |
| Interactor | D3ZAR1 |
| Interactor | P02749 APOH_HUMAN |
| Interactor | Q8NBP7 PCSK9_HUMAN |
| Biological Process | Lipid-metabolism |
| Biological Process | Endocytosis |
| Biological Process | Host-virus-interaction |
| Molecular function | Receptor |
Methods
Biotinylated Human LDLR Protein Tris-Bis PAGE
|
Biotinylated Human LDLR Protein SEC-HPLC
|
